<DOC>
	<DOC>NCT02835469</DOC>
	<brief_summary>The purpose of this study is to investigate the ongoing pregnancy rates at 10-11 weeks after embryo transfer in patients treated with Menopur® Multidose</brief_summary>
	<brief_title>A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>Decision made to prescribe Menopur® multidose according to Summary of product characteristics The study cycle will be either 1st controlled ovarian stimulation cycle ever, or 2nd controlled ovarian stimulation cycle ever, or 1st or 2nd controlled ovarian stimulation cycle after having achieved ongoing pregnancy in a previous controlled ovarian stimulation cycle (note: the subject cannot be included if she has had made more than one failed cycle before the cycle resulting in ongoing pregnancy) Known ovarian disease (e.g. ovarian cysts, polycystic ovarian disease etc.) Diagnosed as "poor responder", defined as either &gt;20 days of gonadotrophin stimulation in a previous controlled ovarian stimulation cycle, or any previous cancellation of a controlled ovarian stimulation cycle due to limited follicular response, or development of less than 4 follicles ≥15 mm in a previous controlled ovarian stimulation cycle Ovarian hyperstimulation syndrome (OHSS)</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>